Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Philips' reports 8% growth:

This article was originally published in Clinica

Executive Summary

Sales at Philips' medical systems business recorded above average growth, contributing to the 8% increase reported for Professional Products and Services in the first half of 1996 (ended June 30th). Sales in this division were Fl 5,010 million ($2,947 million), representing nominal growth of 3% on the same period in the previous year. The division's operational loss was Fl 81 million, compared with Fl 73 million the previous year. Philips' group sales were Fl 31,799 million, reflecting nominal growth of 9%. Adjusted for currency effects, this represents growth of 7%. Net income was Fl 236 million, compared with Fl 1,327 million last year.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT088664

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel